Cerus

United States
Townshend, Vermont, United States, 94520

Company profile

Cerus company profile

Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development.

Business identity

Phone number
9252886001
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$10M-$100M
Founded
1991-09-01, Month

Headquarters

Postal code
94520
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$190.8M
Last funding
Post IPO Equity / $63.3M / 2020-01-28
Last equity funding
Post IPO Equity / $63.3M
Investors
1
Founders
3
Articles
146
Exited on
1997-01-31

Founders and investors

Founders

B.J. CassinLaurence M. CorashStephen T. Isaacs

Investors

Oxford Finance LLC